| |
| |
|
| Insider
Information: |
Gelone Steven P. |
| Relationship: |
Director |
| City: |
King Of Prussia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,283 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,625 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,283 |
|
|
| Total
Value |
$5,625 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nabriva Therapeutics AG |
NBRV |
Director |
2023-01-29 |
14,283 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Chief Development OfficerOffic |
• – – |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,274 |
|
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Scientific Officer |
• – – |
2018-06-23 |
4 |
B |
$3.82 |
$38,200 |
D/D |
10,000 |
22,740 |
2.74 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2023-01-29 |
4 |
D |
$1.50 |
$210 |
D/D |
(140) |
14,283 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President & COO |
• – – |
2019-08-21 |
4/A |
S |
$2.08 |
$17,068 |
D/D |
(8,206) |
47,570 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President & COO |
• – – |
2020-01-31 |
4 |
D |
$1.35 |
$11,679 |
D/D |
(8,651) |
171,919 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President & COO |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
155,000 |
326,919 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President & COO |
• – – |
2020-02-28 |
4 |
D |
$1.35 |
$818 |
D/D |
(606) |
337,858 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2019-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,250 |
55,776 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2019-08-21 |
4 |
D |
$2.08 |
$17,068 |
D/D |
(8,206) |
47,570 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-03-31 |
4 |
D |
$0.58 |
$348 |
D/D |
(606) |
337,252 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-04-30 |
4 |
D |
$0.55 |
$332 |
D/D |
(606) |
336,646 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-05-31 |
4 |
D |
$1.14 |
$716 |
D/D |
(628) |
342,205 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-06-30 |
4 |
D |
$0.67 |
$424 |
D/D |
(628) |
341,577 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-07-31 |
4 |
D |
$0.76 |
$477 |
D/D |
(628) |
340,949 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,250 |
368,199 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-08-20 |
4 |
D |
$0.65 |
$5,026 |
D/D |
(7,761) |
360,438 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-08-31 |
4 |
D |
$0.62 |
$389 |
D/D |
(628) |
359,810 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-09-30 |
4 |
D |
$0.53 |
$335 |
D/D |
(628) |
359,182 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-10-31 |
4 |
D |
$0.50 |
$311 |
D/D |
(628) |
358,554 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-11-30 |
4 |
D |
$0.43 |
$268 |
D/D |
(628) |
357,926 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2020-12-31 |
4 |
D |
$2.42 |
$152 |
D/D |
(63) |
35,729 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
42,500 |
78,229 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2021-01-31 |
4 |
D |
$2.62 |
$197 |
D/D |
(75) |
78,154 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2021-02-06 |
4 |
D |
$2.90 |
$3,202 |
D/D |
(1,104) |
76,924 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• – – |
2021-02-28 |
4 |
D |
$2.39 |
$151 |
D/D |
(63) |
78,091 |
0 |
- |
|
71 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
